Dr. Charles Stankovic is a manager of the Regulatory Affairs at Ash Stevens Inc., a pharmaceutical contract manufacturing organization. He works with Ash Stevens’ clients in the application of QbD principles to advance their chemical development and process qualification activities for regulatory approval. He has over 20 years experience in drug discovery and development. He has a BS in chemistry from Bucknell University (1984), an MS in organic chemistry from Yale University (1988), and earned his Ph.D. at Harvard University (1990), where he studied under Professor Stuart Schreiber.